Development and validation of two nomograms for predicting overall survival and Cancer-specific survival in prostate cancer patients with bone metastases: a population-based study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Development and validation of two nomograms for predicting overall survival and Cancer-specific survival in prostate cancer patients with bone metastases: a population-based study ; volume:23 ; number:1 ; day:5 ; month:12 ; year:2023 ; pages:1-17 ; date:12.2023
BMC urology ; 23, Heft 1 (5.12.2023), 1-17, 12.2023
- Creator
-
Li, Baochao
Xing, Jiajun
Wang, Zhongyuan
Gong, Zixuan
Wang, Zengjun
Xu, Aiming
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12894-023-01372-w
- URN
-
urn:nbn:de:101:1-2024022011452512243623
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Li, Baochao
- Xing, Jiajun
- Wang, Zhongyuan
- Gong, Zixuan
- Wang, Zengjun
- Xu, Aiming
- SpringerLink (Online service)
Other Objects (12)
Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer
Nomograms for predicting overall survival and cancer-specific survival in elderly patients with epithelial ovarian cancer
Development and validation of Nomograms for predicting overall survival and Cancer-specific survival in patients with ovarian clear cell carcinoma
Nomograms predicting cancer-specific survival for stage IV colorectal cancer with synchronous lung metastases
Development and validation of nomograms for predicting overall survival and cancer-specific survival in elderly patients with locally advanced gastric cancer: a population-based study
Development and evaluation of nomograms and risk stratification systems to predict the overall survival and cancer-specific survival of patients with hepatocellular carcinoma
The novel prognostic nomograms for predicting cancer-specific survival and overall survival in mixed medullary and follicular cell carcinoma: A SEER-based study
Development and validation of nomograms predicting overall and cancer-specific survival for non-metastatic primary malignant bone tumor of spine patients
Improvement in overall and cancer-specific survival in contemporary, metastatic prostate cancer chemotherapy exposed patients
Nomogram predicting long-term overall and cancer-specific survival of patients with buccal mucosa cancer
Establishment and validation of nomogram models for overall survival and cancer-specific survival in spindle cell sarcoma patients
Nomogram for predicting the overall survival and cancer-specific survival of patients with intraductal carcinoma of the prostate
Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer
Nomograms for predicting overall survival and cancer-specific survival in elderly patients with epithelial ovarian cancer
Development and validation of Nomograms for predicting overall survival and Cancer-specific survival in patients with ovarian clear cell carcinoma
Nomograms predicting cancer-specific survival for stage IV colorectal cancer with synchronous lung metastases
Development and validation of nomograms for predicting overall survival and cancer-specific survival in elderly patients with locally advanced gastric cancer: a population-based study
Development and evaluation of nomograms and risk stratification systems to predict the overall survival and cancer-specific survival of patients with hepatocellular carcinoma
The novel prognostic nomograms for predicting cancer-specific survival and overall survival in mixed medullary and follicular cell carcinoma: A SEER-based study
Development and validation of nomograms predicting overall and cancer-specific survival for non-metastatic primary malignant bone tumor of spine patients
Improvement in overall and cancer-specific survival in contemporary, metastatic prostate cancer chemotherapy exposed patients
Nomogram predicting long-term overall and cancer-specific survival of patients with buccal mucosa cancer
Establishment and validation of nomogram models for overall survival and cancer-specific survival in spindle cell sarcoma patients
Nomogram for predicting the overall survival and cancer-specific survival of patients with intraductal carcinoma of the prostate
Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer
Nomograms for predicting overall survival and cancer-specific survival in elderly patients with epithelial ovarian cancer
Development and validation of Nomograms for predicting overall survival and Cancer-specific survival in patients with ovarian clear cell carcinoma
Nomograms predicting cancer-specific survival for stage IV colorectal cancer with synchronous lung metastases
Development and validation of nomograms for predicting overall survival and cancer-specific survival in elderly patients with locally advanced gastric cancer: a population-based study
Development and evaluation of nomograms and risk stratification systems to predict the overall survival and cancer-specific survival of patients with hepatocellular carcinoma
The novel prognostic nomograms for predicting cancer-specific survival and overall survival in mixed medullary and follicular cell carcinoma: A SEER-based study
Development and validation of nomograms predicting overall and cancer-specific survival for non-metastatic primary malignant bone tumor of spine patients
Improvement in overall and cancer-specific survival in contemporary, metastatic prostate cancer chemotherapy exposed patients
Nomogram predicting long-term overall and cancer-specific survival of patients with buccal mucosa cancer
Establishment and validation of nomogram models for overall survival and cancer-specific survival in spindle cell sarcoma patients